Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 – Allied Market Research

Posted on

A new report by Allied Market Research, titled, “Global Syphilis Testing Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 20142020“, forecasts the global syphilis testing market to reach $3.6 billion by 2020. The secondary syphilis testing would continue to be the largest market segment through 2020. Latin America, Middle East & Africa (LAMEA) market accounted for about 43% revenue share of the global syphilis testing market in 2014.

To request more information about the report, visit the website at:  https://www.alliedmarketresearch.com/syphilis-testing-market

Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results – thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.

LAMEA and Asia Pacific constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions.

Key findings of the study:

  • LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period
  • United states remains a major market in North America syphilis testing market through 2020
  • Spain and Germany collectively accounts for about one fourth of the Europe syphilis testing market
  • China and India collectively accounts for about 89% share in the Asia Pacific syphilis testing market

The major players in the syphilis testing market space are focusing on technological advancements, product & service innovation in order to retain their position in the market. Major companies profiled in the report include Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Alere Inc., Cepheid Inc., Affymetrix, Inc. and Diasorin.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s